Abstract

Pleurodesis plays an important role in the management of pneumothorax, especially among patients who underwent curative lung cancer resection. Previous papers reported the efficacy of pleurodesis with OK-432, talc, or other cytotoxic agents, but these agents sometimes trigger lethal complications. Recently, several institutions reported 50% glucose solution as pleurodesis for pneumothorax. And we adopt it for post-operative pneumothorax patients. We report the feasibility of pleurodesis with 50% glucose solution for post-operative pneumothorax, after curative lung cancer resection. From October 2014 to March 2016, 13 cases of post-operative pneumothorax after curative lung cancer resection were treated in our hospital. They were treated with pleurodesis with a 50% glucose solution. 200 mL of a 50% glucose solution with 10 mL of 1% lidocaine was instilled into the pleural cavity. Patients regularly change their positions for 2 hours, due to immerse whole visceral pleura. Pleurodesis was repeated until the air leakage stopped. The subjects were 10 men and 3 women, with a mean age of 71 years. 9 patients were past or current smokers. All cases underwent video-assisted-thoracic-surgery (VATS) lobectomy, and Right upper/middle/lower/Left upper/lower lobe resections were 5/2/3/2/1 cases each. Air leakage stopped after pleurodesis in all cases, and 2 cases required pleurodesis twice. No patient required re-operation, and was suffered from high fever, chest pain, or other complications. Drain tube was removed in 2.9 days after pleurodesis on average, and there was no post-treatment recurrence. These results demonstrated feasibility of pleurodesis with a 50% glucose solution for post-operative pneumothorax, after curative lung cancer resection. This procedure can be the first choice for post-operative pneumothorax treatment.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call